Carbon Monoxide Poisoning
36
4
4
12
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
16.7%
6 terminated out of 36 trials
66.7%
-19.8% vs benchmark
11%
4 trials in Phase 3/4
8%
1 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (36)
Maternal Smoking Exposure and Newborn Outcomes: A Study Using Cord Blood Cotinine
Adjunct Targeted Temperature Management in Acute Severe Carbon Monoxide Poisoning
Carbon Monoxide Hyperbaric Oxygen With Steroid Therapy
Optimal Number of Hyperbaric Oxygen Treatments for Carbon Monoxide Poisoning
The Efficacy of Dexamethasone in Combination With N-acetylcysteine in Preventing Neurocognitive Sequelae Due to Carbon Monoxide Poisoning
Comparison of the Effectiveness of Treatments in Carbon Monoxide Intoxications
Microparticles Blood Level in Acute Carbon Monoxide Poisoning
Hyperbaric Oxygen for Carbon Monoxide Induced Chronic Encephalopathy
Cardiotoxicity of Carbon Monoxide in Patients Treated With Hyperbaric Oxygen Therapy
CARbon monoxidE intoxiCatiOn in Korea: Prospective Cohort (CARE CO Cohort)
Carbon Monoxide Blood and DNA Biorepository
The Efficacy of L-Carnitine in the Management of Acute Carbon Monoxide Poisoning
Normal Quantitative EEG (qEEG) Dataset
Utility of Non-invasive Carboxyhemoglobin and Total Hemoglobin Measurement in the Emergency Department
Quantitative Assessment of Pupillary Light Reflex in Acute Carbon Monoxide Poisoning
Prognostic Biomarkers in CO Poisoning
Neurological Sequelae in Patients With Acute Carbon Monoxide Poisoning
One vs. Three Hyperbaric Oxygen Treatments for Acute Carbon Monoxide Poisoning
Hyperbaric Oxygen Therapy Initiation Time in Acute Carbon Monoxide Poisoning
Cognitive and Blood Biomarker Assessment After CO Exposure